A Methyl 4-Oxo-4-phenylbut-2-enoate with in Vivo Activity against MRSA that Inhibits MenB in the Bacterial Menaquinone Biosynthesis Pathway.

doi:10.1021/ACSINFECDIS.6B00023

Paper

A Methyl 4-Oxo-4-phenylbut-2-enoate with in Vivo Activity against MRSA that Inhibits MenB in the Bacterial Menaquinone Biosynthesis Pathway.

Published Mar 18, 2016 · Joe S. Matarlo, Yang Lu, F. Daryaee

ACS infectious diseases

Q1 SJR score

23

Citations

0

Influential Citations

Full textSemantic Scholar

Abstract

4-Oxo-4-phenyl-but-2-enoates inhibit MenB, the 1,4-dihydroxyl-2-naphthoyl-CoA synthase in the bacterial menaquinone (MK) biosynthesis pathway, through the formation of an adduct with coenzyme A (CoA). Here, we show that the corresponding methyl butenoates have MIC values as low as 0.35-0.75 µg/mL against drug sensitive and resistant strains of Staphylococcus aureus. Mode of action studies on the most potent compound, methyl 4-(4-chlorophenyl)-4-oxobut-2-enoate (1), reveal that 1 is converted into the corresponding CoA adduct in S. aureus cells, and that this adduct binds to the S. aureus MenB (saMenB) with a Kd value of 2 µM. The antibacterial spectrum of 1 is limited to bacteria that utilize MK for respiration, and the activity of 1 can be complemented with exogenous MK or menadione. Finally, treatment of methicillin-resistant S. aureus (MRSA) with 1 results in the small colony variant phenotype and thus 1 phenocopies knockout of the menB gene. Taken together the data indicate that the antibacterial activity of 1 results from a specific effect on MK biosynthesis. We also evaluated the in vivo efficacy of 1 using two mouse models of MRSA infection. Notably, compound 1 increased survival in a systemic infection model and resulted in a dose-dependent decrease in bacterial load in a thigh infection model, validating MenB as a target for the development of new anti-MRSA candidates.

In Vitro Study

Study Snapshot

Methyl 4-Oxo-4-phenylbut-2-enoate, a potential anti-MRSA agent, inhibits MenB in the bacterial menaquinone biosynthesis pathway, increasing survival and decreasing bacterial load in mouse models of MRSA infection.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

Paper

A Methyl 4-Oxo-4-phenylbut-2-enoate with in Vivo Activity against MRSA that Inhibits MenB in the Bacterial Menaquinone Biosynthesis Pathway.

Sign up to use Study Snapshot

References

Staphylococcus aureus

Aminoglycosides and antifolate agents show high activity against small-colony variants of Staphylococcus aureus, but further research is needed to optimize treatment strategies for these infections.

Mechanism of MenE inhibition by acyl-adenylate analogues and discovery of novel antibacterial agents.

OSB-AMS reduces menaquinone levels in Staphylococcus aureus, but its antibacterial activity is significantly lower than its enzyme inhibition IC50 value.

Thymidine-Dependent Staphylococcus aureus Small-Colony Variants Are Induced by Trimethoprim-Sulfamethoxazole (SXT) and Have Increased Fitness during SXT Challenge

Trimethoprim-sulfamethoxazole (SXT) induces thymidine-dependent Staphylococcus aureus small-colony variants and selects for thyA mutations, providing an advantage for these strains under certain conditions.

Role of small colony variants in persistence of Pseudomonas aeruginosa infections in cystic fibrosis lungs

Small colony variants (SCVs) of Pseudomonas aeruginosa in cystic fibrosis lungs contribute to increased resistance to antibiotics, poor lung function, and prolonged infection persistence, making their study crucial for clinical investigation.

Prolonged and tunable residence time using reversible covalent kinase inhibitors

Targeting noncatalytic cysteines with inverted cyanoacrylamides can enable "residence time by design" for drugs, allowing for longer in vivo target engagement.

Citations

Re-exploration of phenolic compounds from natural waste rice husks: Combined synthesis of novel herbicide and evaluation of herbicidal activity

Compound I-c4, a novel PPO herbicide, shows promise for effective weed control by targeting protoporphyrinogen oxidase and inhibiting its activity in weeds.

Exploring Nitro‐functionalized Bis‐Schiff Bases: Synthesis, Structural Characterization, Antimicrobial, DFT, In‐silico ADME/T and Molecular Docking Studies

L1 and L3 of the synthesized nitro-functionalized bis-Schiff bases show superior antibacterial activity compared to L2, with their electronic properties and binding modes indicating potential drug-like characteristics.

In Vitro and In Vivo Antimicrobial Activity of an Oxidative Stress-Mediated Bicyclic Menaquinone Biosynthesis Inhibitor against MRSA.

Menaquinone biosynthesis inhibitors show potential as effective antimicrobial agents against MRSA, inhibiting biofilm formation and reducing bacterial lung load without toxicity.

GC-MS Analysis, Antibacterial, and Anticancer Activities of Hibiscus sabdariffa L. Methanolic Extract: In Vitro and In Silico Studies

The methanol extract of Hibiscus sabdariffa L. is the most effective against resistant bacteria and shows promising anticancer properties against Caco-2 cells.

Allosteric inhibition of Staphylococcus aureus MenD by 1,4-dihydroxy naphthoic acid: a feedback inhibition mechanism of the menaquinone biosynthesis pathway

Feedback inhibition by DHNA is a conserved mechanism in Staphylococcus aureus MenD, potentially impacting the development of anti-staphylococcal agents targeting MK biosynthesis.

Comparative Studies to Uncover Mechanisms of Action of N-(1,3,4-Oxadiazol-2-yl)benzamide Containing Antibacterial Agents.

Halogenated N-(1,3,4-oxadiazol-2-yl)benzamides show potential as new antibacterial agents against MRSA, with their mechanism of action involving iron starvation and regulation of essential proteins.

Advances in menaquinone biosynthesis: sublocalisation and allosteric regulation.

Recent discoveries on protein-level allostery and sublocalization of membrane-bound enzymes have provided insights into the regulation of menaquinone biosynthesis in bacteria, with potential applications in energy generation and bone health.